1-3 of 3
Eva-Laure Matera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction

Ivana Spasevska, Eva Laure Matera, Kamel Chettab, Jade Ville, Marie Potier-Cartereau, Lars Petter Jordheim, Catherine Thieblemont, Denis Sahin, Christian Klein, Charles Dumontet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (11): 2371–2381.
https://doi.org/10.1158/1535-7163.MCT-19-0839
Published: 03 November 2020
View article titled, Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction
Open the PDF for Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction in another window
Includes: Supplementary data
Journal Articles

Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies

Sébastien Cornet, Doriane Mathé, Kamel Chettab, Anne Evesque, Eva-Laure Matera, Olivier Trédan, Charles Dumontet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (6): 1238–1247.
https://doi.org/10.1158/1535-7163.MCT-15-0759
Published: 02 June 2016
View article titled, Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies
Open the PDF for Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies in another window
Includes: Supplementary data
Journal Articles

Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells

Rouba Hage-Sleiman, Stéphanie Herveau, Eva-Laure Matera, Jean-Fabien Laurier, Charles Dumontet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (2): 303–312.
https://doi.org/10.1158/1535-7163.MCT-10-0568
Published: 08 February 2011
View article titled, Silencing of <em>Tubulin Binding Cofactor C</em> Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Open the PDF for Silencing of <em>Tubulin Binding Cofactor C</em> Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells in another window
Includes: Supplementary data